Infection, Fungal
8
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
PK/PD of Caspofungin in Children Severe Infection
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture Positivity in Intensive Care
PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
Point-of-care Tests for Bacterial Vaginosis and Candidosis
Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.
Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis